ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Immunogenic Nanovesicle-Tandem-Augmented Chemoimmunotherapy via Efficient Cancer-Homing Delivery and Optimized Ordinal-Interval Regime.

Mengchi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.